Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonas Mattsson

Showing results (51-60 of 258) with videos related to

Pageof 26
Sort By:
Blood|October 24, 2002
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantationMehmet Uzunel, Jonas Mattsson, Mats Brune, et al.
Expert Review of Clinical Immunology|April 6, 2013
Systems level immune response analysis and personalized medicinePetter Brodin, Davide Valentini, Michael Uhlin, et al.
Cytotherapy|June 4, 2018
Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor T cellsRehab Alnabhan, Ahmed Gaballa, Lisa-Mari Mörk, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 10, 2018
CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN-γ Production ProfileIsabelle Magalhaes, Ingrid Kalland, James N Kochenderfer, et al.
European Journal of Haematology|February 21, 2008
Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemiaMats Remberger, Jonas Mattsson, Dan Hausenberger, et al.
Transplant Immunology|September 21, 2011
WITHDRAWN: Treatment with mesenchymal stromal cells does not improve long-term survival in patients with severe acute GVHDMats Remberger, Michael Uhlin, Helen Karlsson, et al.
Idcases|September 5, 2022
Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantationIan Pang, Sanjay Singhabahu, Igor Novitzky-Basso, et al.
Oral Diseases|October 4, 2020
Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxisKarin Garming Legert, Olle Ringdén, Mats Remberger, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2009
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantationMichael Uhlin, Mantas Okas, Jens Gertow, et al.
Clinical Drug Investigation|November 2, 2013
Comparison of algorithms for oral busulphan area under the concentration-time curve limited sampling estimateFredrik Sjöö, Ibrahim El-Serafi, Jon Enestig, et al.
Pageof 26

Showing results (51-60 of 258) with videos related to

Sort By:
Pageof 26
Blood|October 24, 2002
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantationMehmet Uzunel, Jonas Mattsson, Mats Brune, et al.
Expert Review of Clinical Immunology|April 6, 2013
Systems level immune response analysis and personalized medicinePetter Brodin, Davide Valentini, Michael Uhlin, et al.
Cytotherapy|June 4, 2018
Media evaluation for production and expansion of anti-CD19 chimeric antigen receptor T cellsRehab Alnabhan, Ahmed Gaballa, Lisa-Mari Mörk, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|January 10, 2018
CD19 Chimeric Antigen Receptor T Cells From Patients With Chronic Lymphocytic Leukemia Display an Elevated IFN-γ Production ProfileIsabelle Magalhaes, Ingrid Kalland, James N Kochenderfer, et al.
European Journal of Haematology|February 21, 2008
Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemiaMats Remberger, Jonas Mattsson, Dan Hausenberger, et al.
Transplant Immunology|September 21, 2011
WITHDRAWN: Treatment with mesenchymal stromal cells does not improve long-term survival in patients with severe acute GVHDMats Remberger, Michael Uhlin, Helen Karlsson, et al.
Idcases|September 5, 2022
Intrathecal cytomegalovirus immunoglobulin for CMV encephalitis post allogeneic stem cell transplantationIan Pang, Sanjay Singhabahu, Igor Novitzky-Basso, et al.
Oral Diseases|October 4, 2020
Oral mucositis after tacrolimus/sirolimus or cyclosporine/methotrexate as graft-versus-host disease prophylaxisKarin Garming Legert, Olle Ringdén, Mats Remberger, et al.
Cancer Immunology, Immunotherapy : CII|November 13, 2009
A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantationMichael Uhlin, Mantas Okas, Jens Gertow, et al.
Clinical Drug Investigation|November 2, 2013
Comparison of algorithms for oral busulphan area under the concentration-time curve limited sampling estimateFredrik Sjöö, Ibrahim El-Serafi, Jon Enestig, et al.
Pageof 26